Home/Filings/4/0001142576-10-000029
4//SEC Filing

Shue Youe Kong 4

Accession 0001142576-10-000029

CIK 0001142576other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 7:47 PM ET

Size

5.0 KB

Accession

0001142576-10-000029

Insider Transaction Report

Form 4
Period: 2010-05-17
Shue Youe Kong
VP, clinical Development
Transactions
  • Other

    Common stock

    2010-05-17$9.57/sh+1,161$11,11283,809 total
Footnotes (1)
  • [F1]Acquired under the Company's employee stock purchase plan on May 17, 2010.

Issuer

OPTIMER PHARMACEUTICALS INC

CIK 0001142576

Entity typeother

Related Parties

1
  • filerCIK 0001380841

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 7:47 PM ET
Size
5.0 KB